First Citizens Bank & Trust CO Abbott Laboratories Transaction History

First Citizens Bank & Trust CO

$6.53 Billion
Q3 2024

A detailed history of First Citizens Bank & Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 89,889 shares of ABT stock, worth $10.3 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

89,889

Previous 89,800 0.1%

Holding current value

$10.3 Million

Previous $9.33 Million 9.83%

% of portfolio

0.16%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$100.07 - $118.13 $8,906 - $10,513	89 Added 0.1%	89,889 $10.2 Million
Q2 2024 Jul 19, 2024	BUY	$100.73 - $112.44 $190,379 - $212,511	1,890 Added 2.15%	89,800 $9.33 Million
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $3.7 Million - $4.08 Million	33,743 Added 62.29%	87,910 $9.99 Million
Q4 2023 Jan 22, 2024	SELL	$90.19 - $110.4 $275,530 - $337,272	-3,055 Reduced 5.34%	54,167 $5.96 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $42,892 - $51,464	-449 Reduced 0.78%	57,222 $5.54 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $1.01 Million - $1.13 Million	10,045 Added 21.09%	57,671 $6.29 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $740,882 - $872,062	7,649 Added 19.13%	47,626 $4.82 Million
Q4 2022 Jan 24, 2023	BUY	$95.06 - $111.52 $234,703 - $275,342	2,469 Added 6.58%	39,977 $4.39 Million
Q3 2022 Oct 20, 2022	SELL	$96.76 - $112.03 $859,712 - $995,386	-8,885 Reduced 19.15%	37,508 $3.63 Million
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $201,996 - $244,149	-1,979 Reduced 4.09%	46,393 $5.04 Million
Q1 2022 Apr 26, 2022	BUY	$114.02 - $139.04 $98,627 - $120,269	865 Added 1.82%	48,372 $5.73 Million
Q4 2021 Mar 11, 2022	BUY	$115.53 - $141.46 $482,568 - $590,878	4,177 Added 9.64%	47,507 $6.69 Million
Q3 2021 Oct 15, 2021	SELL	$116.66 - $129.06 $591,116 - $653,947	-5,067 Reduced 10.47%	43,330 $5.12 Million
Q2 2021 Jul 14, 2021	BUY	$105.79 - $124.53 $418,822 - $493,014	3,959 Added 8.91%	48,397 $5.61 Million
Q1 2021 Apr 14, 2021	SELL	$108.84 - $128.23 $69,004 - $81,297	-634 Reduced 1.41%	44,438 $5.33 Million
Q4 2020 Jan 13, 2021	SELL	$105.0 - $114.42 $27,825 - $30,321	-265 Reduced 0.58%	45,072 $4.93 Million
Q3 2020 Oct 15, 2020	SELL	$91.64 - $111.29 $333,936 - $405,540	-3,644 Reduced 7.44%	45,337 $4.93 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $81,853 - $104,762	-1,069 Reduced 2.14%	48,981 $4.48 Million
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $277,475 - $405,745	4,417 Added 9.68%	50,050 $3.95 Million
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $131,268 - $146,132	-1,672 Reduced 3.53%	45,633 $3.96 Million
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $240,855 - $261,161	-2,943 Reduced 5.86%	47,305 $3.96 Million
Q2 2019 Jul 11, 2019	BUY	$72.88 - $85.0 $182,272 - $212,585	2,501 Added 5.24%	50,248 $4.23 Million
Q1 2019 Apr 12, 2019	SELL	$66.22 - $80.06 $402,551 - $486,684	-6,079 Reduced 11.29%	47,747 $3.82 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $9,047 - $10,249	-138 Reduced 0.26%	53,826 $3.89 Million
Q3 2018 Oct 18, 2018	SELL	$60.81 - $73.36 $135,606 - $163,592	-2,230 Reduced 3.97%	53,964 $3.96 Million
Q2 2018 Jul 11, 2018	BUY	$57.57 - $63.54 $72,135 - $79,615	1,253 Added 2.28%	56,194 $3.43 Million
Q1 2018 Apr 11, 2018	SELL	$56.27 - $63.62 $1.48 Million - $1.67 Million	-26,325 Reduced 32.39%	54,941 $3.29 Million
Q4 2017 Jan 10, 2018	SELL	$53.68 - $57.47 $450,160 - $481,943	-8,386 Reduced 9.35%	81,266 $4.64 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $4.31 Million - $4.81 Million	89,652	89,652 $4.78 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.

Account

First Citizens Bank & Trust CO Abbott Laboratories Transaction History